Inhibikase Therapeutics Price Chart
Inhibikase Therapeutics Volume Chart
Inhibikase Therapeutics Market Segments
After Hours
+0.00(+0.00%)
| Open | $1.96 |
|---|---|
| Close | $1.96 |
| Low | $1.96 |
| Low Change | 0.00 (0.00%) |
| High | $1.96 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 1.886K |
| Dollar Volume | $3.70K |
Regular Trading Hours
-0.01(-0.51%)
| Open | $1.98 |
|---|---|
| Close | $1.97 |
| Low | $1.95 |
| Low Change | -0.03 (-1.52%) |
| High | $2.06 |
| High Change | +0.08 (+4.04%) |
| Range | $0.11 |
| Volume | 1.058M |
| Dollar Volume | $2.08M |
Premarket
+0.00(+0.00%)
| Open | $2.01 |
|---|---|
| Close | $2.01 |
| Low | $2.01 |
| Low Change | 0.00 (0.00%) |
| High | $2.01 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 100 |
| Dollar Volume | $201.12 |
After Hours Yesterday
+0.00(+0.00%)
| Open | $1.93 |
|---|---|
| Close | $1.93 |
| Low | $1.93 |
| Low Change | 0.00 (0.00%) |
| High | $1.93 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 146 |
| Dollar Volume | $281.78 |
Regular Trading Hours Yesterday
-0.04(-1.98%)
| Open | $2.02 |
|---|---|
| Close | $1.98 |
| Low | $1.96 |
| Low Change | -0.06 (-2.97%) |
| High | $2.06 |
| High Change | +0.04 (+1.73%) |
| Range | $0.10 |
| Volume | 1.174M |
| Dollar Volume | $2.32M |
Premarket Yesterday
*No Trades in Segment
Inhibikase Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.99 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.95 |
| 20 Day Moving Average (SMA20) | $1.93 |
| 50 Day Moving Average (SMA50) | $1.79 |
| 100 Day Moving Average (SMA100) | $1.69 |
| 200 Day Moving Average (SMA200) | $1.72 |
Inhibikase Therapeutics Statistics
| Average Volume (30 Days) | 2.6M |
|---|---|
| P/E Ratio (Current) | -5.13 |
| EPS (Current) | -$0.39 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$25.63M |
| Cash Ratio | 5.72 |
| Current Ratio | 11.73 |
| Quick Ratio | 11.73 |
| Debt to Equity | 0.00 |
| Enterprise Value | $204.26M |
| EV to EBITDA | -4.00 |
| EV to Sales | — |
| Price to Book | 3.33 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.60% |
| Return on Equity | -0.65% |
Inhibikase Therapeutics Stock Splits
There has been 1 stock split for Inhibikase Therapeutics (IKT). The reverse stock split occured on June 30, 2023 and reduced the outstanding shares at a ratio of 6:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 30, 2023 | Reverse | 6:1 |
Inhibikase Therapeutics Dividends
There have been no dividends for Inhibikase Therapeutics (IKT).